An update on the status of potent inhibitors of Metallo-β-lactamases

Scientia Pharmaceutica

Volumn 81, Issue 2, 2013, Pages 309-327

  Faridoon, ^a   Ul Islam, Nazar ^b  

^a ISLAMIA COLLEGE UNIVERSITY   (Pakistan)

^b UNIVERSITY OF PESHAWAR   (Pakistan)

Author keywords

lactam analogues; Biphenyl tetrazoles; Inhibition; Metallo beta lactamases; Peptides; Thiol; Triazoles

Indexed keywords

BETA LACTAMASE INHIBITOR; BIPHENYL TETRAZOLE; HETROCYCLIC DISULFIDE; METALLO BETA LACTAMASE; NATURAL PRODUCT; PENICILLIN DERIVATIVE; PEPTIDE; PHENAZINE; PHTHALIC ACID DERIVATIVE; PYRIDINE DICARBOXYLATE; PYRROLE DERIVATIVE; SINGLE STRANDED DNA; SUCCINIC ACID DERIVATIVE; SULFONIC ACID DERIVATIVE; THIOL DERIVATIVE; THIOMANDELIC ACID; THIOSEMICARBAZIDE DERIVATIVE; TRIAZOLE DERIVATIVE; TRIFLUOROMETHYL ALCOHOL; TRIFLUOROMETHYL KETONE; UNCLASSIFIED DRUG;

DRUG SYNTHESIS; ENZYME INHIBITION; NONHUMAN; REVIEW;

EID: 84879302319     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1302-08     Document Type: Review

References (60)

1. Masuda N, Sakagawa E, Ohya S. Outer membrane proteins responsible for multiple drug resistance in pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995; 39: 645-649. http://dx.doi.org/10.1128/AAC.39.3.645
2. Vella P, Hussein WM, Leung EWW, Clayton D, Ollis DL, Mitic N, McGeary PR. The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening. Bioorg Med Chem Lett. 2011; 21: 3282-3285. http://dx.doi.org/10.1016/j.bmcl.2011.04.027
3. Ambler RP. The structure of beta-lactamases. Philos Trans R Soc London B. 1980; 289: 321-331. http://dx.doi.org/10.1098/rstb.1980.0049
4. Felici A, Amicosante G, Oratore A, Strom R, Ledent P, Joris B, Fanuel L, Frère JM. An overview of the kinetic parameters of class B beta-lactamases. Biochem J. 1993; 291: 151-155. http://www.ncbi.nlm.nih.gov/pubmed/8471035
5. Gilpin ML, Fluston M, Payne D, Cramp R, Hood I. Isolation and structure determination of two novel phenazines from a streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase. J Antibiot. 1995; 48: 1081-1085. http://dx.doi.org/10.7164/antibiotics.48.1081
6. Payane DJ, Bateson JH, Gasson BC, Proctor D, Khushi T, Farmar TH, Tolson DA, Bell D, Skett PW, Marshall AC, Reid R, Ghosez L, Combret Y, Marchand-Brynaert J. Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob Agents Chemother. 1997; 41: 135-140. http://www.ncbi.nlm.nih.gov/pubmed/8980769
7. Greenlee ML, Laub JB, Balkovec JM, Hammond ML, Hammond GG, Pompliano DL, Epstein-Toney JH. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 Metallo-β-Lactamase. Bioorg Med Chem Lett. 1999; 9: 2549-2554. http://dx.doi.org/10.1016/S0960-894X(99)00425-4
8. Bounanga S, Laws AP, Galleni M, Page MI. The mechanism of catalysis and the inhibition of the Bacillus cereuszinc-dependent β-lactamase. Biochem J. 1998; 331: 703-711. http://www.ncbi.nlm.nih.gov/pubmed/9560295
9. Yang KW, Crowder MW. Inhibition Studies on the Metallo-β-lactamase L1 from Stenotrophomonas maltophilia. Arch Biochem Biophys. 1999; 368: 1-6. http://dx.doi.org/10.1006/abbi.1999.1293
10. Mollard C, Moali C, Papamicael C, Christian Damblon C, Vessilier S, Amicosante G, Schofield CJ, Galleni M, Frere J-M, Roberts GCK. Thiomandelic Acid, a Broad Spectrum Inhibitor of Zinc_β-Lactamases. J Biol Chem. 2001; 276: 45015-45023. http://dx.doi.org/10.1074/jbc.M107054200
11. Kurosaki H, Yamaguchi Y, Higashi T, Soga K, Matsueda S, Yumoto H, Misumi S, Yamagata Y, Arakawa Y, Goto M. Irreversible Inhibition of Metallo-b-lactamase (IMP-1) by 3-(3-Mercaptopropionylsulfanyl)-propionic Acid Pentafluorophenyl Ester. Angew Chem Int Ed. 2005; 44: 3861-3864. http://dx.doi.org/10.1002/anie.200500835
12. Siemann S, Clarke AJ, Viswanatha T, Dmitrienko GI. Thiols as Classical and Slow-Binding Inhibitors of IMP-1 and Other Binuclear Metallo-β-lactamases. Biochemistry. 2003; 42: 1673-1683. http://dx.doi.org/10.1021/bi027072i
13. Liénard BMR, Hüting R, Lassaux P, Galleni M, Frère J-M, Schofield CJ. Dynamic Combinatorial Mass Spectrometry Leads to Metallo-β-lactamase Inhibitors J Med Chem. 2008; 51: 684-688. http://dx.doi.org/10.1021/jm070866g
14. Heinz U, Bauer R, Wommer S, Meyer-Klaucke W, Papamichaels C, Bateson J, Adolph HW. Coordination Geometries of Metal Ions in D-or L-Captopril-inhibited Metallo-β-lactamases. J Biol Chem. 2003; 278: 20659-20666. http://dx.doi.org/10.1074/jbc.M212581200
15. Liénard BM, Garau G, Horsfall L, Karsisiotis AI, Damblon C, Lassaux P, Papamicael C, Roberts GC, Galleni M, Dideberg O, Frère JM, Schofield CJ. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols. Org Biomol Chem. 2008; 6: 2282-2294. http://dx.doi.org/10.1039/b802311e
16. Lassaux P, Hamel M, Gulea M, Delbrück H, Mercuri PS, Horsfall L, Dehareng D, Kupper M, Frère JM, Hoffmann K, Galleni M, Bebrone C. Mercaptophosphonate Compounds as Broad-Spectrum Inhibitors of the Metallo-β-lactamases. J Med Chem. 2010; 53: 4862-4876. http://dx.doi.org/10.1021/jm100213c
17. Yamaguchi Y, Jin W, Matsunaga K, Ikemizu S, Yamagata Y, Wachino J, Shibata N, Arakawa Y, Kurosaki H. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor. J Med Chem. 2007; 50: 6647-6653. http://dx.doi.org/10.1021/jm701031n
18. Jin W, Arakawa Y, Yasuzawa H, Taki T, Hashiguchi R, Mitsutani K, Shoga A, Yamaguchi Y, Kurosaki H, Shibata N, Ohta M, Goto M. Comparative study of the inhibition of metallo--lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group. Biol Pharm Bull. 2004; 27: 851-856. http://dx.doi.org/10.1248/bpb.27.851
19. Concha NO, Janson CA, Rowling P, Pearson S, Cheever CA, Clarke BP, Lewis C, Galleni M, Frère JM, Payne DJ, Bateson JH, Abdel-Meguid SS. Crystal Structure of the IMP-1 Metallo β-Lactamase from Pseudomonas aeruginosa and Its Complex with a Mercaptocarboxylate Inhibitor:Binding Determinants of a Potent, Broad-Spectrum Inhibitor. Biochemistry. 2000; 39: 4288-4298. http://dx.doi.org/10.1021/bi992569m
20. Gelb MH, Svaren JP, Abeles RH. Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry. 1985; 24: 1813-1817. http://dx.doi.org/10.1021/bi00329a001
21. Brady K, Wei A, Ringe D, Abeles RH. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. Biochemistry. 1990; 29: 7600-7607. http://dx.doi.org/10.1021/bi00485a009
22. Christianson DW, Lipscomb WN. Complex between carboxypeptidase A and a possible transition-state analog: mechanistic inferences from high-resolution x-ray structures of enzyme-inhibitor complexes. J Am Chem Soc. 1986; 108: 4998-5003. http://dx.doi.org/10.1021/ja00276a048
23. Walter MW, Felici A, Galleni M, Soto RP, Adlington RM, Baldwin JE, Frère J-M, Gololobov M, Schofield CJ. Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases. Bioorg Med Chem Lett. 1996; 6: 2455-2458. http://dx.doi.org/10.1016/0960-894X(96)00453-2
24. Walter MW, Adlington RM, Baldwin JE, Schofield CJ. Synthesis of metallo-β-lactamase inhibitors. Tetrahedron. 1997; 53: 7275-7290. http://dx.doi.org/10.1016/S0040-4020(97)00404-3
25. Toney JH, Fitzgerald PM, Grover-Sharma N, Olson SH, May WJ, Sundelof JG, Vanderwall DE, Cleary KA, Grant SK, Wu JK, Kozarich JW, Pompliano DL, Hammond GG. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallobeta-lactamase. Chem Biol. 1998; 5: 185-198. http://dx.doi.org/10.1016/S1074-5521(98)90632-9
26. Toney JH, Cleary KA, Hammond GG, Yuan X, May WJ, Hutchins SM, Ashton WT, Vanderwall DE. Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors. Bioorg Med Chem Lett. 1999; 9: 2741-2746. http://dx.doi.org/10.1016/S0960-894X(99)00458-8
27. Toney JH, Hammond GG, Fitzgerald PM, Sharma N, Balkovec JM, Rouen GP, Olson SH, Hammond ML, Greenlee ML, Gao YD. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase. J Biol Chem. 2001; 276: 31913-31918. http://dx.doi.org/10.1074/jbc.M104742200
28. Moloughney JG, D. Thomas J, Toney JH. Novel IMP-1 metallo-β-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1. FEMS Microbiol Lett. 2005; 243: 65-71. http://dx.doi.org/10.1016/j.femsle.2004.11.042
29. Olsen L, Jost S, Adolph H-W, Pettersson I, Hemmingsen L, Jørgensen FS. New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design. Bioorg Med Chem. 2006; 14: 2627-2635. http://dx.doi.org/10.1016/j.bmc.2005.11.046
30. Hiraiwa Y, Morinaka A, Fukushima T, Kudo T. Metallo-β-lactamase inhibitory activity of phthalic acid derivatives. Bioorg Med Chem Lett. 2009; 19: 5162-5165. http://dx.doi.org/10.1016/j.bmcl.2009.07.018
31. Walter MW, Valladares MH, Adlington RM, Amicosante G, Baldwin JE, Frère J-M, Galleni M, Rossolini GR, Schofield CJ. Hydroxamate Inhibitors ofAeromonas hydrophilaAE036 Metallo-B-lactamase. Bioorg Chem. 1999; 27: 35-40. http://dx.doi.org/10.1006/bioo.1998.1111
32. Liénard BMR, Horsfall LE, Galleni M, Frère J-M, Schofield CJ. Inhibitors of the FEZ-1 metallo-β-lactamase. Bioorg Med Chem Lett. 2007; 17: 964-968. http://dx.doi.org/10.1016/j.bmcl.2006.11.053
33. Nagano R, Adachi Y, Imamura H, Yamada K, Hashizume T, Morishima H. Carbapenem derivatives as potential inhibitors of various β-lactamases, including class B metallo-β-lactamases. Antimicrob Agents Chemother. 1999; 43: 2497-2503. http://www.ncbi.nlm.nih.gov/pubmed/10508031
34. Nagano R, Adachi Y, Hashizume T, Morishima H. In vitro antibacterial activity and mechanism of action of J.-111,225, a novel 1β-methylcarbapenem, against transferable IMP-1 metallo-β-lactamase producers. J Antimicrob Chemother. 2000; 45: 271-276. http://dx.doi.org/10.1093/jac/45.3.271
35. Hovel FV, Vanwetswinkell S, Marchand-Brynaertt J, FasWez J. Synthesis and rearrangment of potential zinc β-lactamase inhibitors. Tetrahedron Lett. 1995; 36: 9313-9316. http://dx.doi.org/10.1016/0040-4039(95)02028-N
36. Buynak JD, Chen H, Vogeti L, Gadhachanda VR, Buchanan CA, Palzkill T, Shaw RW, Spencer J, Walsh TR. Penicillin-derived inhibitors that simultaneously target both metallo-and serine-β-lactamases. Bioorg Med Chem Lett. 2004; 14: 1299-1304. http://dx.doi.org/10.1016/j.bmcl.2003.12.037
37. Tsang WY, Dhanda A, Schofield CJ, Frère J-M, Galleni M, Page MI. The inhibition of metallo-β-lactamase by thioxo-cephalosporin derivatives. Bioorg Med Chem Lett. 2004; 14: 1737-1739. http://dx.doi.org/10.1016/j.bmcl.2004.01.047
38. Badarau A, Llinás A, Laws AP, Damblon C, Page MI. Inhibitors of Metallo-β-lactamase Generated from β-Lactam Antibiotics. Biochemistry. 2005; 44: 8578-8589. http://dx.doi.org/10.1021/bi050302j
39. Beharry Z, Chen H, Gadhachanda VR, Buynak JD, Palzkill T. Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis. Biochem Biophys Res Commun. 2004; 313: 541-545. http://dx.doi.org/10.1016/j.bbrc.2003.11.158
40. Ganta SR, Perumal S, Pagadala SR, Samuelsen O, Spencer J, Pratt RF, Buynak JD. Approaches to the simultaneous inactivation of metallo-and serine-beta-lactamases. Bioorg Med Chem Lett. 2009; 19: 1618-1622. http://dx.doi.org/10.1016/j.bmcl.2009.02.018
41. Johnson JW, Gretes M, Goodfellow VJ, Marrone L, Heynen ML, Strynadka NC, Dmitrienko GI. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine-and metallo-beta-lactamases. J Am Chem Soc. 2010; 132: 2558-2560. http://dx.doi.org/10.1021/ja9086374
42. Sanschagrin F, Levesque RC. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display. J Antimicrob Chemother. 2005; 55: 252-255. http://dx.doi.org/10.1093/jac/dkh550
43. Bounaga S, Galleni M, Laws AP, Page MI. Cysteinyl peptide Inhibitors of Bacillus cereus Zinc β-Lactamase. Bioorg Med Chem. 2001; 9: 503-510. http://dx.doi.org/10.1016/S0968-0896(00)00257-1
44. Sun Q, Law A, Crowder MW, Geysen HM. Homo-cysteinyl peptide inhibitors of the L1 metallo-β-lactamase, and SAR as determined by combinatorial library synthesis. Bioorg Med Chem Lett. 2006; 16: 5169-5175. http://dx.doi.org/10.1016/j.bmcl.2006.07.001
45. Horsfall LE, Garau G, Liénard BMR, Dideberg O, Schofield CJ. Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother. 2007; 51: 2136-2142. http://dx.doi.org/10.1128/AAC.00866-06
46. Roll DM, Yang Y, Wildey MJ, Bush K, Lee MD. Inhibition of metallo-beta-lactamases by pyridine monothiocarboxylic acid analogs. J Antibiot. 2010; 63: 255-257. http://dx.doi.org/10.1038/ja.2010.20
47. Payne DJ, Hueso-Rodríguez JA, Boyd H, Concha NO, Janson CA, Gilpin M, Bateson JH, Cheever C, Niconovich NL, Pearson S, Rittenhouse S, Tew D, Díez E, Pérez P, De La Fuente J, Rees M, RiveraSagredo A. Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallobeta-lactamases. Antimicrob Agents Chemother. 2002; 46:1880-1886. http://dx.doi.org/10.1128/AAC.46.6.1880-1886.2002
48. Denny BJ, Lambert PA, West PWJ. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. FEMS Microbiol Lett. 2002; 208: 21-24. http://www.ncbi.nlm.nih.gov/pubmed/11934488
49. Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol. 2007; 74: 1686-1701. http://dx.doi.org/10.1016/j.bcp.2007.05.021
50. Walsh TR, Tolemman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microb Rev. 2005; 18: 306-325. http://www.ncbi.nlm.nih.gov/pubmed/15831827
51. Docquier JD, Lamotte-Brasseur J, Galleni M, Amicosante G, Frere JM, Rossolini GM. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J Antimicrob Chemother. 2003; 51: 257-266. http://dx.doi.org/10.1093/jac/dkg067
52. Minond D, Saldanha SA, Subramaniam P, Spaargaren M, Spicer T, Fotsing JR, Weide T, Fokin VV, Sharpless KB, Galleni M, Bebrone C, Lassaux P, Hodder P. Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries. Bioorg Med Chem. 2009; 17: 5027-5037. http://dx.doi.org/10.1016/j.bmc.2009.05.070
53. Weide T, Saldanha SA, Minond D, Spicer TP, Fotsing JR, Spaargaren M, Frère JM, Bebrone C, Sharpless KB, Hodder PS, Fokin VV. NH-1,2,3-Triazole-based Inhibitors of the VIM-2 Metallo-β-Lactamase: Synthesis and Structure-Activity Studies. ACS Med Chem Lett. 2010; 1: 150-154. http://dx.doi.org/10.1021/ml900022q
54. Faridoon, Hussein WM, Vella P, Islam NU, Ollis DL, Schenk G, McGeary RP. 3-Mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors. Bioorg Med Chem Lett. 2012; 22: 380-386. http://dx.doi.org/10.1016/j.bmcl.2011.10.116
55. Tamilselvi A, Mugesh G. Metallo-β-lactamase-Catalyzed Hydrolysis of Cephalosporins: Some Mechanistic Insights into the Effect of Heterocyclic Thiones on Enzyme Activity. Inorg Chem. 2011; 50: 749-756. http://dx.doi.org/10.1021/ic100253k
56. Mohamed MS, Hussein WM, McGeary RP, Vella P, Schenk G, Abd El-hameed RH. Synthesis and kinetic testing of new inhibitors for a metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Eur J Med Chem. 2011;46: 6075-6082. http://dx.doi.org/10.1016/j.ejmech.2011.10.030
57. Kim S-K, Sims CL, Wozniak SE, Drude SH, Whitson D, Shaw RW. Antibiotic resistance in bacteria: novel metalloenzyme inhibitors. Chem Biol Drug Des. 2009; 74: 343-348. http://dx.doi.org/10.1111/j.1747-0285.2009.00879.x
58. Siemann S, Evanoff DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI. N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother. 2002; 46: 2450-2457. http://dx.doi.org/10.1128/AAC.46.8.2450-2457.2002
59. Fitzgerald PMD, Wu JK, Toney JH. Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. Biochemistry. 1998; 37: 6791-6800. http://dx.doi.org/10.1021/bi9730339
60. Simm AM, Loveridge EJ, Crosby J, Avison MB, Walsh TR, Bennett PM. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases. Biochem J. 2005; 387: 585-590. http://dx.doi.org/10.1042/BJ20041542/ul